These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21362515)

  • 21. Imaging Tumor Metastases with Molecular Probes.
    Qiao R; Zhu R; Gao M
    Curr Pharm Des; 2015; 21(42):6260-4. PubMed ID: 26503140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
    Sano K
    Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI biosensors: a short primer.
    Louie A
    J Magn Reson Imaging; 2013 Sep; 38(3):530-9. PubMed ID: 23996662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional magnetic resonance imaging probes.
    Kluza E; Strijkers GJ; Nicolay K
    Recent Results Cancer Res; 2013; 187():151-90. PubMed ID: 23179881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR molecular imaging of tumor vasculature and vascular targets.
    Pathak AP; Penet MF; Bhujwalla ZM
    Adv Genet; 2010; 69():1-30. PubMed ID: 20807600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer.
    Mustafi D; Peng B; Foxley S; Makinen MW; Karczmar GS; Zamora M; Ejnik J; Martin H
    J Biol Inorg Chem; 2009 Nov; 14(8):1187-97. PubMed ID: 19572156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular-targeted micelles as a specific MRI contrast agent for molecular imaging of fibrin clots and cancer cells.
    Vorobiev V; Adriouach S; Crowe LA; Lenglet S; Thomas A; Chauvin AS; Allémann E
    Eur J Pharm Biopharm; 2021 Jan; 158():347-358. PubMed ID: 33271302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and magnetic resonance imaging: The value of immunoliposomes.
    Kozlowska D; Foran P; MacMahon P; Shelly MJ; Eustace S; O'Kennedy R
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1402-11. PubMed ID: 19796661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy Monitoring with Functional and Molecular MR Imaging.
    García-Figueiras R; Padhani AR; Baleato-González S
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):261-288. PubMed ID: 26613885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging of cell surface receptors using targeted contrast agents.
    Artemov D; Bhujwalla ZM; Bulte JW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):485-94. PubMed ID: 15579038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.
    Xue S; Qiao J; Pu F; Cameron M; Yang JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):163-79. PubMed ID: 23335551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.
    Benz MR; Vargas HA; Sala E
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):1-10. PubMed ID: 26613872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A biomarker-responsive T
    Daryaei I; Randtke EA; Pagel MD
    Magn Reson Med; 2017 Apr; 77(4):1665-1670. PubMed ID: 27090199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
    Fattahi H; Laurent S; Liu F; Arsalani N; Vander Elst L; Muller RN
    Nanomedicine (Lond); 2011 Apr; 6(3):529-44. PubMed ID: 21542690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioengineered probes for molecular magnetic resonance imaging in the nervous system.
    Hsieh V; Jasanoff A
    ACS Chem Neurosci; 2012 Aug; 3(8):593-602. PubMed ID: 22896803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI contrast agents: current status and future perspectives.
    Strijkers GJ; Mulder WJ; van Tilborg GA; Nicolay K
    Anticancer Agents Med Chem; 2007 May; 7(3):291-305. PubMed ID: 17504156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Imaging of Tumor Metabolism with ¹H Magnetic Resonance Spectroscopy.
    Martín Noguerol T; Sánchez-González J; Martínez Barbero JP; García-Figueiras R; Baleato-González S; Luna A
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):57-86. PubMed ID: 26613876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
    Choyke PL; Dwyer AJ; Knopp MV
    J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging.
    Medarova Z; Balcioglu M; Yigit MV
    Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.
    Gu JT; Nguyen L; Chaudhari AJ; MacKenzie JD
    Top Magn Reson Imaging; 2011 Apr; 22(2):61-9. PubMed ID: 22648081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.